Contact Information
Company Information
Company
Visus Therapeutics, Inc.
Total Funding
126000000.0
Technologies
Outlook
Amazon AWS
Cloudflare DNS
Microsoft Office 365
WP Engine
Greenhouse.io
Barracuda Networks
Mobile Friendly
Google Tag Manager
Typekit
Vimeo
Google Font API
QuickBooks
Remote
AI
Keywords
presbyopia
ophthalmology
optometry
eye health
glaucoma
macular degeneration
dry eye disease
amd
ocular surface disease
regenerative medicine
biotechnology research
biopharmaceutical
cataracts
geographic atrophy
ocular health
eye therapy
vision restoration
clinical development
eye care
ophthalmic drugs
brimochol
injectable therapy
microdosing
novel therapies
patient-centric
chronic eye conditions
vision impairment
innovative pipeline
optical health
maintenance of vision
pupil-modulating drops
eye drops
disease mechanisms
treatment options
drug approval
clinical trials
sight loss prevention
patient solutions
combination therapies
fda-approved
retinal health
vision restoration therapies
ophthalmic indications
topical treatment
non-surgical options
new chemical entities
side effect mitigation
long-acting treatments
visual acuity improvement
near vision
treatment of presbyopia
cell-based therapy
treatment of geographical atrophy
restoration of vision
targeted therapy
eye care professionals
comprehensive therapeutics
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans